Nadex Advertisement
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

ADMA Biologics, Inc. (ADMA)

Add ADMA Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 6/16/2017 2:49:31 PM - Followers: 6 - Board type: Free - Posts Today: 0

ADMA Biologics, Inc. 465 Route 17 South Ramsey, NJ 07446 United States Phone: 201-478-5552 Fax: 201-478-5553 Website: ADMA Biologics, Inc., a late stage biopharmaceutical company, develops, manufactures, and intends to market plasma-based biologics for the treatment and prevention of infectious diseases. Its lead product candidate, RI-002, which is in Phase III clinical trial, is intended for the treatment of primary immune deficiency disease. RI-002 is an injectable immune globulin derived from human plasma enriched with high levels of naturally occurring polyclonal antibodies, as well as high levels of antibodies targeted to respiratory syncytial virus. The company also operates ADMA BioCenters, which are plasma collection centers. ADMA Biologics, Inc. was founded in 2004 and is headquartered in Ramsey, New Jersey.
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#3   Biotest AG has filed a new activist 13D, wiltonio 06/16/17 02:49:31 PM
#2   ADMA moved from OTCBB to the Nasdaq NCM: Renee 11/07/14 04:33:39 PM
#1   $ADMA DD Notes ~ stocktrademan 10/19/14 02:21:41 PM